These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
815 related articles for article (PubMed ID: 20634482)
1. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482 [TBL] [Abstract][Full Text] [Related]
2. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT; J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584 [TBL] [Abstract][Full Text] [Related]
3. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356 [TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519 [TBL] [Abstract][Full Text] [Related]
5. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. Kwong DL; Sham JS; Au GK; Chua DT; Kwong PW; Cheng AC; Wu PM; Law MW; Kwok CC; Yau CC; Wan KY; Chan RT; Choy DD J Clin Oncol; 2004 Jul; 22(13):2643-53. PubMed ID: 15226332 [TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739 [TBL] [Abstract][Full Text] [Related]
7. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180 [TBL] [Abstract][Full Text] [Related]
9. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526 [TBL] [Abstract][Full Text] [Related]
10. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma. Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
12. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. Chua DT; Sham JS; Au GK Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880 [TBL] [Abstract][Full Text] [Related]
13. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. Chan AT; Leung SF; Ngan RK; Teo PM; Lau WH; Kwan WH; Hui EP; Yiu HY; Yeo W; Cheung FY; Yu KH; Chiu KW; Chan DT; Mok TS; Yau S; Yuen KT; Mo FK; Lai MM; Ma BB; Kam MK; Leung TW; Johnson PJ; Choi PH; Zee BC J Natl Cancer Inst; 2005 Apr; 97(7):536-9. PubMed ID: 15812080 [TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma. Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594 [TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. Hui EP; Ma BB; Leung SF; King AD; Mo F; Kam MK; Yu BK; Chiu SK; Kwan WH; Ho R; Chan I; Ahuja AT; Zee BC; Chan AT J Clin Oncol; 2009 Jan; 27(2):242-9. PubMed ID: 19064973 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109 [TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]